- Home
- PETS vs PAVM Comparison
PETS vs PAVM Comparison
Compare PETS & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PETS | PAVM |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | United States |
| Employees | N/A | 41 |
| Industry | Retail-Drug Stores and Proprietary Stores | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6M | 60.1M |
| IPO Year | 2003 | N/A |
Fundamental Metrics
Financial Performance| Metric | PETS | PAVM |
|---|---|---|
| Price | $2.35 | $9.16 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.20 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 73.8K | 9.6K |
| Earning Date | 02-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $273,800,000.00 | N/A |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | $2.98 | $64.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $0.21 |
| 52 Week High | $4.32 | $28.44 |
Technical Indicators
Market Signals| Indicator | PETS | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 39.65 | 44.06 |
| Support Level | $2.19 | $8.47 |
| Resistance Level | $2.93 | $9.26 |
| Average True Range (ATR) | 0.10 | 0.52 |
| MACD | 0.02 | -0.07 |
| Stochastic Oscillator | 57.14 | 39.81 |
Price Performance
Historical ComparisonAbout PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.